Comprehensive laboratory testing for gene therapies

Gene therapies offer a new method of treatment and have historically been focused on patients with rare genetic diseases. The successful approvals for therapies focused on rare disorders has led, increasingly, to development of advanced therapies targeting more prevalent diseases. Whether you're developing a viral delivered-based gene therapy, such as an adeno-associated virus or lentivirus product, or applying gene editing technologies such as CRISPR-Cas9, we can support your laboratory assessments across the development continuum.To help you handle the unique challenges and complexities you face with developing these precision medicines, we provide a wide range of preclinical, CMC release and clinical testing across our in-house and specialty laboratories. Working together, we'll collaborate on a custom approach that will match the expert support you need to move your critical gene therapy projects forward.

Copy and paste this URL:

https://biopharma.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/salessheets/155550_DD_SS_CGTAssay.pdf